Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11111 | 31036530 | EBioMedicine | A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease. | 2019 | Details |
| A11112 | 31036494 | Ann Hepatol | Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). | 2019 | Details |
| A11113 | 31035998 | BMC Med | Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity. | 2019 | Details |
| A11114 | 31035991 | BMC Complement Altern Med | The Alisma and Rhizoma decoction abates nonalcoholic steatohepatitis-associated liver injuries in mice by modulating oxidative stress and autophagy. | 2019 | Details |
| A11115 | 31035507 | Nutrients | Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. | 2019 | Details |
| A11116 | 31035006 | Free Radic Biol Med | Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity. | 2019 | Details |
| A11117 | 31034714 | Mol Nutr Food Res | Pear Extract and Malaxinic Acid Reverse Obesity, Adipose Tissue Inflammation, and Hepatosteatosis in Mice. | 2019 | Details |
| A11118 | 31034092 | Hepatology | Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum. | 2019 | Details |
| A11119 | 31034016 | J Clin Endocrinol Metab | Associations of plasma CD36 and body fat distribution. | 2019 | Details |
| A11120 | 31033805 | J Clin Gastroenterol | Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B. | 2020 | Details |
| A11122 | 31033142 | Liver Int | Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. | 2019 | Details |
| A11123 | 31032942 | J Cell Physiol | Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway. | 2019 | Details |
| A11124 | 31032705 | Autophagy | Lysosomal inhibition attenuates peroxisomal gene transcription via suppression of PPARA and PPARGC1A levels. | 2019 | Details |
| A11125 | 31031702 | Front Endocrinol (Lausanne) | The Discovery and Development of Liraglutide and Semaglutide. | 2019 | Details |
| A11126 | 31031700 | Front Neurol | The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke. | 2019 | Details |
| A11127 | 31031531 | J Med Ultrasound | Correlational Study of Nonalcoholic Fatty Liver Disease Diagnosed by Ultrasonography with Lipid Profile and Body Mass Index in Adult Nepalese Population. | 2018 | Details |
| A11128 | 31031166 | Ann Hepatol | Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11129 | 31030165 | J Nutr Biochem | Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2019 | Details |
| A11130 | 31029756 | J Ethnopharmacol | Antisteatotic and antioxidant activities of Thymbra spicata L. extracts in hepatic and endothelial cells as in vitro models of non-alcoholic fatty liver disease. | 2019 | Details |
| A11131 | 31029645 | Clin Res Hepatol Gastroenterol | Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks. | 2019 | Details |
| A11132 | 31028903 | Pharmacol Res | Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH. | 2019 | Details |
| A11133 | 31028350 | Nat Rev Gastroenterol Hepatol | From NASH to HCC: current concepts and future challenges. | 2019 | Details |
| A11134 | 31027316 | Nutrients | Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome. | 2019 | Details |
| A11135 | 31027093 | Medicine (Baltimore) | Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes: A case report. | 2019 | Details |
| A11136 | 31026873 | Planta Med | Preventive Effects of Total Flavonoid C-Glycosides from Abrus mollis on Nonalcoholic Fatty Liver Disease through Activating the PPARα Signaling Pathway. | 2019 | Details |
| A11137 | 31026768 | Redox Biol | Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1. | 2019 | Details |
| A11138 | 31026041 | Swiss Med Wkly | Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience. | 2019 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11140 | 31024446 | Front Endocrinol (Lausanne) | ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease. | 2019 | Details |
| A11141 | 31024206 | J Clin Exp Hepatol | Systems Challenges of Hepatic Carcinomas: A Review. | 2018 | Details |
| A11142 | 31024203 | J Clin Exp Hepatol | Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography. | 2018 | Details |
| A11143 | 31024201 | J Clin Exp Hepatol | Redefining the Normal Values of Serum Aminotransferases in Healthy Indian Males. | 2018 | Details |
| A11144 | 31024200 | J Clin Exp Hepatol | The Impact of Ethnic Subgroups on Tumor Stage at Diagnosis, Treatment Received, and Long-Term Survival Among Asian Adults With Hepatocellular Carcinoma. | 2018 | Details |
| A11145 | 31024199 | J Clin Exp Hepatol | Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance. | 2018 | Details |
| A11146 | 31024089 | Nat Rev Gastroenterol Hepatol | Past, present and future perspectives in nonalcoholic fatty liver disease. | 2019 | Details |
| A11148 | 31023717 | Biol Open | Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. | 2019 | Details |
| A11149 | 31022865 | Nutrients | Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats. | 2019 | Details |
| A11151 | 31020834 | Anal Chem | Dual Energy Transfer-Based Fluorescent Nanoprobe for Imaging miR-21 in Nonalcoholic Fatty Liver Cells with Low Background. | 2019 | Details |
| A11154 | 31020720 | Exp Physiol | Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice. | 2019 | Details |
| A11155 | 31019719 | Glob Health Epidemiol Genom | Non-alcoholic fatty liver disease in Africa: a hidden danger. | 2019 | Details |
| A11156 | 31019294 | Lab Invest | Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages. | 2019 | Details |
| A11157 | 31018719 | Expert Rev Gastroenterol Hepatol | Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11158 | 31018673 | Angiology | The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease. | 2019 | Details |
| A11159 | 31018538 | Int J Mol Sci | Lipid Modulating Anti-oxidant Stress Activity of Gastrodin on Nonalcoholic Fatty Liver Disease Larval Zebrafish Model. | 2019 | Details |
| A11160 | 31017556 | Int J Vitam Nutr Res | Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11161 | 31016455 | Obes Surg | The HAALT Non-invasive Scoring System for NAFLD in Obesity. | 2019 | Details |
| A11162 | 31015871 | Pharm Pract (Granada) | The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials. | 2019 | Details |
| A11163 | 31014948 | Surg Obes Relat Dis | Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery. | 2019 | Details |
| A11164 | 31013988 | Nutrients | A Slow-Digesting Carbohydrate Diet during Rat Pregnancy Protects Offspring from Non-Alcoholic Fatty Liver Disease Risk through the Modulation of the Carbohydrate-Response Element and Sterol Regulatory Element Binding Proteins. | 2019 | Details |
| A11165 | 31013454 | Metab Syndr Relat Disord | In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium. | 2019 | Details |
| A11166 | 31013363 | Hepatology | MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial). | 2019 | Details |
| A11167 | 31013265 | Med Sci Monit | Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance. | 2019 | Details |
| A11168 | 31013163 | Endocr Pract | FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETES. | 2019 | Details |
| A11169 | 31012869 | JCI Insight | Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. | 2019 | Details |
| A11170 | 31012257 | Int J Rheum Dis | Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice. | 2019 | Details |
| A11171 | 31011515 | Anal Cell Pathol (Amst) | Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging? | 2019 | Details |
| A11172 | 31011312 | Case Rep Gastroenterol | Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases. | 2019 | Details |
| A11173 | 31011302 | Gastroenterol Hepatol (N Y) | Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11174 | 31011258 | World J Gastroenterol | Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. | 2019 | Details |
| A11175 | 31010457 | Gene Expr | Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis. | 2019 | Details |
| A11176 | 31010354 | Free Radic Res | Evaluation of the therapeutic potential effect of Fas receptor gene knockdown in experimental model of non-alcoholic steatohepatitis. | 2019 | Details |
| A11177 | 31010049 | Int J Mol Sci | Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. | 2019 | Details |
| A11179 | 31009793 | Clin Gastroenterol Hepatol | Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes. | 2019 | Details |
| A11180 | 31009403 | Clin Transl Gastroenterol | Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions! | 2019 | Details |
| A11181 | 31009401 | Eur J Gastroenterol Hepatol | The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis. | 2019 | Details |
| A11182 | 31009107 | J Cell Biochem | Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway. | 2019 | Details |
| A11183 | 31008924 | Medicine (Baltimore) | Metabolic characteristics of obese children with fatty liver: A STROBE-compliant article. | 2019 | Details |
| A11184 | 31008808 | Eur J Gastroenterol Hepatol | Hepatocellular carcinoma in the noncirrhotic liver: a literature review. | 2019 | Details |
| A11185 | 31008094 | Prev Nutr Food Sci | Long-Term Feeding of Soy Protein Attenuates Choline Deficient-Induced Adverse Effects in Wild Type Mice and Prohibitin 1 Deficient Mice Response More Sensitively. | 2019 | Details |
| A11186 | 31007691 | J Res Med Sci | A randomized controlled trial comparing effects of a low-energy diet with n-3 polyunsaturated fatty acid supplementation in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11187 | 31007175 | Biochim Biophys Acta Mol Basis Dis | Outside the liver box: The gut microbiota as pivotal modulator of liver diseases. | 2018 | Details |
| A11188 | 31007045 | Antioxid Redox Signal | Peroxiredoxin 6 Confers Protection Against Nonalcoholic Fatty Liver Disease Through Maintaining Mitochondrial Function. | 2019 | Details |
| A11190 | 31005808 | Phytomedicine | Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice. | 2018 | Details |
| A11191 | 31004931 | Environ Toxicol Pharmacol | Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells. | 2019 | Details |
| A11192 | 31004828 | Cell Mol Gastroenterol Hepatol | Metabolic Targets in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11194 | 31004758 | Clin Gastroenterol Hepatol | Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies. | 2019 | Details |
| A11195 | 31004566 | Biochem Pharmacol | Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors. | 2019 | Details |
| A11196 | 31004178 | Arch Toxicol | A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic mice. | 2019 | Details |
| A11197 | 31004037 | J Biol Chem | Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice. | 2019 | Details |
| A11198 | 31003450 | Nutrients | Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. | 2019 | Details |
| A11199 | 31002999 | Int Immunopharmacol | CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease. | 2019 | Details |
| A11201 | 31002661 | PLoS Comput Biol | Investigating the deregulation of metabolic tasks via Minimum Network Enrichment Analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data. | 2019 | Details |
| A11203 | 31001964 | Clin Mol Hepatol | Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio. | 2019 | Details |
| A11204 | 31000862 | J Pak Med Assoc | Expert Opinion: Use of sodium glucose co-transporter type-2 inhibitors in South Asian population -The Pakistan perspective. | 2019 | Details |
| A11206 | 30999770 | Scand J Gastroenterol | Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation. | 2019 | Details |
| A11207 | 30999670 | Cells | Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11209 | 30998190 | Ann Biol Clin (Paris) | [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker]. | 2019 | Details |
| A11210 | 30995792 | Int J Mol Sci | Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism. | 2019 | Details |
| A11211 | 30995640 | Med Princ Pract | Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11212 | 30993937 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment. | 2019 | Details |
| A11213 | 30993748 | Hepatology | The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials. | 2019 | Details |
| A11214 | 30993598 | Hepatol Int | Bi-lobar liver biopsy via EUS enhances the assessment of disease severity in patients with non-alcoholic steatohepatitis. | 2019 | Details |
| A11215 | 30993553 | Clin Drug Investig | Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2019 | Details |
| A11216 | 30991959 | BMC Gastroenterol | Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. | 2019 | Details |
| A11217 | 30991877 | Gut Microbes | High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. | 2019 | Details |
| A11218 | 30991446 | Hepatology | Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11219 | 30991275 | Sleep Med | The impact of the sleep duration on NAFLD score in Korean middle-aged adults: a community-based cohort study. | 2019 | Details |
| A11221 | 30987865 | Clin Investig Arterioscler | Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes. | 2019 | Details |
| A11222 | 30987634 | BMC Pediatr | Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard. | 2019 | Details |
| A11223 | 30987167 | Int J Mol Sci | Ameliorative Effect of Spinach on Non-Alcoholic Fatty Liver Disease Induced in Rats by a High-Fat Diet. | 2019 | Details |